PERFUSE THERAPEUTICS
LIVE

Serial Number

97873326

Owner

Perfuse Therapeutics, Inc.

Attorney

Jessica L. Rothstein

First Use Date

Dec 31, 2018

Filing Date

Apr 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PERFUSE THERAPEUTICS Trademark

Serial Number: 97873326 • Registration: 7372185

PERFUSE THERAPEUTICS is a trademark filed by Perfuse Therapeutics, Inc. on April 4, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Perfuse Therapeutics, Inc.

1700 Owens Street, Suite 540
San Francisco, CA 94158

Entity Type: 03

Trademark Details

Filing Date

April 4, 2023

Registration Date

April 30, 2024

First Use Anywhere

December 31, 2018

First Use in Commerce

December 31, 2018

Published for Opposition

February 13, 2024

Goods & Services

research and development of therapeutics for the treatment of ocular disease

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 30, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2024 CNEA
ASSIGNED TO EXAMINER
Dec 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2023 NWOS
NEW APPLICATION ENTERED
Apr 7, 2023 NWAP